Clodinafop-propargyl TC, WP, EC
CLODINAFOP-PROPARGYL TECHNICAL MATERIAL
FAO specification 683.225 / TC (June 2020)
This specification, which is PART ONE of this publication, is based on an evaluation of data submitted by the manufacturers whose name are listed in the evaluation reports (683.225/2006 & 683.225/2019). It should be applicable to TC produced by this manufacturer but it is not an endorsement of it, nor a guarantee that it complies with the specification. The specification may not be appropriate for TC produced by other manufacturers. The evaluation reports 683.225/2006 & 683.225/2019, as PART TWO, form an integral part of this publication.
1 Description
The material shall consist of clodinafop-propargyl together with related manufacturing impurities and shall be a white or light beige to light brown powder, free from visible extraneous matter and added modifying agents.
2 Active ingredient
2.1 Identity tests (683/TC/M/2, CIPAC Handbook M, p. 27, 2009)
The active ingredient shall comply with an identity test and, where the identity remains in doubt, shall comply with at least one additional test.
2.2 Clodinafop-propargyl content (683/TC/M/3.1 and 683/TC/M/3.2, CIPAC Handbook M, p. 27 and p. 30, 2009) (Note 1)
The clodinafop-propargyl content shall be declared (not less than 960 g/kg) and, when determined, the average measured content shall not be lower than the declared minimum content.
CLODINAFOP-PROPARGYL WETTABLE POWDER
FAO Specification 683.225 / WP (June 2020)
This specification, which is PART ONE of this publication, is based on an evaluation of data submitted by the manufacturer whose name is listed in the evaluation report (683.225/2006). It should be applicable to relevant products of this manufacturer, and those of any other formulators who use only TC from the evaluated source. The specification is not an endorsement of those products, nor a guarantee that they comply with the specification. The specification may not be appropriate for the products of manufacturers who use TC from other sources. The evaluation report 683.225/2006, as PART TWO, forms an integral part of this publication.
1 Description
The material shall consist of technical clodinafop-propargyl, complying with the requirements of FAO Specification 683.225/TC (June 2020), together with filler(s) and any other necessary formulants. It shall be in the form of a fine powder free from visible extraneous matter and hard lumps.
2 Active ingredient
2.1 Identity tests (683.225/WP/M/2, CIPAC Handbook M, p. 32, 2009)
The active ingredient shall comply with an identity test and, where the identity remains in doubt, shall comply with at least one additional test.
2.2 Clodinafop-propargyl content (683.225/WP/M/3.1 and 683.225/WP/M/3.2, CIPAC Handbook M, p. 32, 2009), (Note 1)
The clodinafop-propargyl content shall be declared (g/kg) and, when determined, the average measured content shall not differ from that declared by more than the following tolerance:
Declared content, g/kg | Tolerance |
above 100 up to 250 Note: the upper limit is included in the range | ± 6% of the declared content |
3 Physical properties
3.1 pH range (MT 75.3, CIPAC Handbook J, p.131, 2000)
The pH of an aqueous dispersion shall be 4.0 to 8.0.
3.2 Wet sieve test (MT 185, CIPAC Handbook K, p.149, 2003)
Maximum: 2% retained on a 75 μm test sieve.
3.3 Suspensibility (MT 184.1) (Notes 2, 3 & 4)
A minimum of 60% of the clodinafop-propargyl content found under 2.2 shall be in suspension after 30 min in CIPAC standard water D at 25 ± 5°C.
3.4 Persistent foam (MT 47.3, CIPAC Handbook O, p.177, 2017) (Note 5)
Maximum: 60 ml after 1 min.
3.5 Wettability (MT 53.3.1, CIPAC Handbook F, p.165, 1995)
The formulation shall be completely wetted in 1 min without swirling.
4 Storage stability
4.2 Stability at elevated temperature (MT 46.4) (Note 6)
After storage at 54 ± 2°C for 14 days, the determined average active ingredient content must not be lower than 95% relative to the determined average content found before storage (Note 7) and the formulation shall continue to comply with the clauses for:
- pH range (3.1),
- wet sieve test (3.2),
- suspensibility (3.3),
- wettability (3.5).
CLODINAFOP-PROPARGYL EMULSIFIABLE CONCENTRATE
FAO Specification 683.225 / EC (June 2020)
This specification, which is PART ONE of this publication, is based on an evaluation of data submitted by the manufacturer whose name is listed in the evaluation report (683.225/2006). It should be applicable to relevant products of this manufacturer, and those of any other formulators who use only TC from the evaluated source. The specification is not an endorsement of those products, nor a guarantee that they comply with the specification. The specification may not be appropriate for the products of manufacturers who use TC from other sources. The evaluation report 683.225/2006, as PART TWO, forms an integral part of this publication.
1 Description
The material shall consist of technical clodinafop-propargyl, complying with the requirements of FAO specification 683.225/TC (June 2020), dissolved in suitable solvents, together with any other necessary formulants. It shall be in the form of a clear to slightly hazy, stable homogeneous liquid, free from visible suspended matter and sediment, to be applied as an emulsion after dilution in water.
2 Active ingredient
2.1 Identity tests (683.225/EC/M/2, CIPAC Handbook M, p. 34, 2009)
The active ingredient shall comply with an identity test and, where the identity remains in doubt, shall comply with at least one additional test.
2.2 Clodinafop-propargyl content (683.225/EC/M/3.1 and 683.225/EC/M/3.2, CIPAC Handbook M, p. 34, 2009) (Note 1)
The clodinafop-propargyl content shall be declared (g/kg or g/l at 20 ± 2ºC, Note 2) and, when determined, the average measured content shall not differ from that declared by more than the following tolerances:
Declared content, g/kg or g/l at 20 ± 2ºC | Tolerance |
above 25 up to 100 above 100 up to 250 Note: the upper limit is included in each range | ± 10% of the declared content ± 6% of the declared content |
3 Physical properties
3.1 pH range (MT 75.3, CIPAC Handbook J, p.131, 2000)
The pH of an aqueous dispersion shall be 4.0 to 8.0.
3.2 Emulsion stability and re-emulsification (MT 36.3, CIPAC Handbook K, p.137, 2003) (Note 3)
The formulation, when diluted at 30 ± 2°C with CIPAC standard waters A and D, shall comply with the following:
Time after dilution | Limits of stability | |
0 h 0.5 h 2.0 h
24 h
24.5 h Note: tests at 24 h are required only where the results at 2 h are in doubt. | Initial emulsification complete Cream, maximum: 2 ml "Cream", maximum: 4 ml "Free oil", maximum: trace Re-emulsification complete "Cream", maximum: 2 ml "Free oil" maximum: trace. | |
3.3 Persistent foam (MT 47.3, CIPAC Handbook O, p.177, 2017) (Note 4)
Maximum: 40 ml after 1 min.
4 Storage stability
4.1 Stability at 0°C (MT 39.3, CIPAC Handbook J, p.126, 2000)
After storage at 0 ± 2°C for 7 days, the volume of solid and/or liquid which separates shall not be more than 0.3 ml.
4.2 Stability at elevated temperature (MT 46.4) (Note 5)
After storage at 54 ± 2°C for 14 days, the determined average active ingredient content must not be lower than 95% relative to the determined average content found before storage (Note 6) and the formulation shall continue to comply with the clauses for:
- pH range (3.1);
- emulsion stability and re-emulsification (3.2).
网站底部信息,在后台关于我们的单页里修改
202-12, Rose Block, Rongqiao Central Garden, No.29
Customer service hotline:+86-25-86269150, 13505155290
Customer service hotline:wangqi@agriglory.com
Copyright ◎2025 Nanjing Agriglory Chemical Co., Lt  京ICP备17006342号-2